20:09:12 EDT Sun 09 Aug 2020
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Pivot Pharmaceuticals Inc
Symbol PVOT
Shares Issued 88,679,077
Close 2019-11-22 C$ 0.125
Recent Sedar Documents

Pivot launches Que. manufacturing facility

2019-11-25 07:21 ET - News Release

Dr. Toni Rinow reports

PIVOT PHARMA LAUNCHES CANADIAN CANNABIS AND NUTRACEUTICAL MANUFACTURING FACILITY

Pivot Pharmaceuticals Inc. has launched its manufacturing facility in Dollard-des-Ormeaux, Que., Canada. Along with research and development and pilot-scale laboratories, this facility comprises 43 000 square feet of production and packaging space designed to optimize the manufacturing processes of Pivot branded value-added CBD (cannabidiol) and nutraceutical consumer products. The production activities are planned to start in the next three months, pending Health Canada licence reception.

Pivot is nearing the completion of its state-of-the-art building and is preparing the submission of its site evidence package to Health Canada, the final step toward securing the Health Canada licence. The infrastructure will be dedicated to the development of novel formulations and production of Pivot's CBD, phytocannabinoid and micronutrient product lines using Pivot's patented and proprietary drug delivery technologies.

"We're delighted to see our Canada-based Dollard-des-Ormeaux facility coming on line, adding to our capacity to produce and deliver our world-class value-added CBD and nutraceutical micro-nutrient formulations in the U.S., Europe and Canada," said Dr. Toni Rinow, chief executive officer of Pivot. "This facility will enable us to launch our product pipeline in the Canadian market and thus further consolidating Pivot's strategic positioning with ramping sales of specialty CBD products and micronutrient formulations in Germany and planed product launches in the U.S. marketplace in Q1 2020."

About Pivot Pharmaceuticals Inc.

Pivot Pharmaceuticals is a science-based innovative medical wellness company aspiring to offer high-quality preventive and self-care solutions to its customers. Pivot has developed pharmaceutical grade products including CBD, phytocannabinoid and micronutrient derived formulations utilizing proprietary drug delivery technologies that are unique, patent protected and with clear superior benefits to the user such as high absorption, low bioburden and ease of use. Pivot is uniquely positioned to execute on its brand leader strategy in its main markets in Germany, United States and Canada.

We seek Safe Harbor.

© 2020 Canjex Publishing Ltd. All rights reserved.